Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Enas

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Neurosurgery|August 1, 1982
The dynamics of neuronal dysfunction and recovery following severe head injury assessed with serial multimodality evoked potentialsP G Newlon, R P Greenberg, M S Hyatt, et al.
Journal of Clinical Psychopharmacology|June 1, 1994
Absence of a relationship between adverse events and suicidality during pharmacotherapy for depressionG D Tollefson, A H Rampey, C M Beasley, et al.
The Journal of Clinical Psychiatry|March 1, 1985
Fluoxetine: clinical pharmacology and physiologic dispositionL Lemberger, R F Bergstrom, R L Wolen, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 1, 1994
Fluoxetine: a randomized clinical trial in the treatment of obesityD J Goldstein, A H Rampey, G G Enas, et al.
AJR. American Journal of Roentgenology|March 1, 1985
Computed tomography in the prediction of outcome in head injuryM H Lipper, P R Kishore, G G Enas, et al.
The American Review of Respiratory Disease|November 1, 1989
Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmaticsE Israel, E F Juniper, J T Callaghan, et al.
Journal of Neurosurgery|June 1, 1981
Improved confidence of outcome prediction in severe head injury. A comparative analysis of the clinical examination, multimodality evoked potentials, CT scanning, and intracranial pressureR K Narayan, R P Greenberg, J D Miller, et al.
International Journal of Obesity|January 1, 1989
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub)L R Levine, G G Enas, W L Thompson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Neurosurgery|August 1, 1982
The dynamics of neuronal dysfunction and recovery following severe head injury assessed with serial multimodality evoked potentialsP G Newlon, R P Greenberg, M S Hyatt, et al.
Journal of Clinical Psychopharmacology|June 1, 1994
Absence of a relationship between adverse events and suicidality during pharmacotherapy for depressionG D Tollefson, A H Rampey, C M Beasley, et al.
The Journal of Clinical Psychiatry|March 1, 1985
Fluoxetine: clinical pharmacology and physiologic dispositionL Lemberger, R F Bergstrom, R L Wolen, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 1, 1994
Fluoxetine: a randomized clinical trial in the treatment of obesityD J Goldstein, A H Rampey, G G Enas, et al.
AJR. American Journal of Roentgenology|March 1, 1985
Computed tomography in the prediction of outcome in head injuryM H Lipper, P R Kishore, G G Enas, et al.
The American Review of Respiratory Disease|November 1, 1989
Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmaticsE Israel, E F Juniper, J T Callaghan, et al.
Journal of Neurosurgery|June 1, 1981
Improved confidence of outcome prediction in severe head injury. A comparative analysis of the clinical examination, multimodality evoked potentials, CT scanning, and intracranial pressureR K Narayan, R P Greenberg, J D Miller, et al.
International Journal of Obesity|January 1, 1989
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub)L R Levine, G G Enas, W L Thompson, et al.
Pageof 2